FDA Approves Immunotherapy to Help Prevent Relapse of Melanoma October 30, 2015December 14, 2022 Matthew Tontonoz
Making It Count: Team CRI Adds On Miles for Cancer Research November 5, 2015December 14, 2022 Jasmine Lingard
Second Annual Immuno-Oncology 360° Conference November 17, 2015December 14, 2022 Arthur N. Brodsky, PhD
First Monoclonal Antibody for Multiple Myeloma Receives FDA Approval November 20, 2015December 14, 2022 Alexandra Mulvey
Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer November 24, 2015December 14, 2022 Arthur N. Brodsky, PhD